Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Day One Biopharmaceuticals Inc (DAWN)

Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,289,820
  • Shares Outstanding, K 100,846
  • Annual Sales, $ 0 K
  • Annual Income, $ -188,920 K
  • EBIT $ -211 M
  • EBITDA $ -211 M
  • 60-Month Beta -1.51
  • Price/Sales 11.17
  • Price/Cash Flow N/A
  • Price/Book 2.26

Options Overview Details

View History
  • Implied Volatility 77.10% ( +16.94%)
  • Historical Volatility 39.94%
  • IV Percentile 64%
  • IV Rank 38.47%
  • IV High 185.90% on 04/12/24
  • IV Low 9.07% on 08/12/24
  • Put/Call Vol Ratio 0.20
  • Today's Volume 397
  • Volume Avg (30-Day) 219
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 10,855
  • Open Int (30-Day) 9,776

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.50
  • Number of Estimates 6
  • High Estimate -0.35
  • Low Estimate -1.16
  • Prior Year -0.64
  • Growth Rate Est. (year over year) +21.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.11 +5.62%
on 12/20/24
14.46 -11.55%
on 12/04/24
-0.83 (-6.09%)
since 11/20/24
3-Month
12.11 +5.62%
on 12/20/24
16.76 -23.69%
on 11/08/24
-1.99 (-13.46%)
since 09/20/24
52-Week
11.94 +7.12%
on 06/17/24
18.07 -29.22%
on 05/01/24
-1.06 (-7.65%)
since 12/20/23

Most Recent Stories

More News
Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference

DAWN : 12.79 (+2.65%)
Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development

DAWN : 12.79 (+2.65%)
Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference

DAWN : 12.79 (+2.65%)
Day One Biopharmaceuticals (DAWN) Stock Soars 11.3% on Strategic Milestones and Promising Outlook

Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) surged 11.3% this morning, reflecting strong investor confidence fueled by a series of favorable developments. This biotech firm focused on advancing...

DAWN : 12.79 (+2.65%)
Day One Reports Third Quarter 2024 Financial Results and Corporate Progress

DAWN : 12.79 (+2.65%)
Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024

DAWN : 12.79 (+2.65%)
Day One Biopharmaceuticals (DAWN) Stock Soars 11.3% on Strategic Milestones and Promising Outlook

Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) surged 11.3% this morning, reflecting strong investor confidence fueled by a series of favorable developments. This biotech firm focused on advancing...

DAWN : 12.79 (+2.65%)
KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that it is supporting...

KZIA : 3.02 (-0.33%)
DAWN : 12.79 (+2.65%)
NVS : 97.11 (+0.35%)
Stock Index Futures Muted as Weak China Trade Data Weighs on Sentiment

June S&P 500 futures (ESM23) are up +0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.09% this morning as weak trade data from China stoked investor concerns over the strength of global demand....

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
WAL : 84.62 (+2.12%)
INTC : 19.52 (+2.41%)
AMD : 119.21 (+0.28%)
COIN : 278.71 (+1.75%)
ITX.E.DX : 50.070 (+1.32%)
YEXT : 6.38 (+0.31%)
GDYN : 20.50 (+0.44%)
VXRT : 0.6196 (+2.70%)
DAWN : 12.79 (+2.65%)
Why Shares of Day One Pharmaceuticals Are Up Monday

The clinical-stage biotech released early trial news regarding its lead therapy candidate.

DAWN : 12.79 (+2.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 14.05
2nd Resistance Point 13.52
1st Resistance Point 13.16
Last Price 12.79
1st Support Level 12.27
2nd Support Level 11.74
3rd Support Level 11.38

See More

52-Week High 18.07
Fibonacci 61.8% 15.73
Fibonacci 50% 15.00
Fibonacci 38.2% 14.28
Last Price 12.79
52-Week Low 11.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar